Treatment Advances in Generalized Myasthenia Gravis: Clinical and Laboratory Criteria for Diagnosis and Optimal Treatment Selection
Vera Bril, MD
Jonathan Strober, MD
Living with gMG: Navigating Personal, Professional, and Mental Health Challenges
Nicholas J. Silvestri, MD
Diagnostic Advances in gMG: Effective Tools and Techniques
Hans Katzberg, MD
Autoantibodies Explained: Anti-AChR, Anti-MuSK, and Their Diagnostic Role
Driving Progress in Cardiology: Exploring the Role of FXI in Acute Coronary Syndromes & Beyond
May 01, 2025
Washington, DC, District of Columbia
Personalizing Care Within the RCC Treatment Paradigm
Eric Jonasch, MD
Brad McGregor, MD
Ulka Vaishampayan, MBBS
What’s New in Glaucoma Topical Therapies?
Justin Schweitzer, OD, FAAO
Sarah H. Van Tassel, MD
New Solutions for Optimizing IOP Control: A Case-Based Approach
What’s New in Schlemm’s Canal MIGS?
Paul Petrakos, DO, MS
I. Paul Singh, MD
What’s New in Subconjunctival MIBS
What’s New With 3D Visualization in Glaucoma Surgery?
Evolving Strategies for Sustained-Release Glaucoma Treatments
Effective MIGS for Optimal IOP Control: A Case-Based Approach
Recent Updates on Ovarian Function Suppression in Premenopausal HR+ Early-Stage Breast Cancer
Sandra Swain, MD
Virginia Kaklamani, MD
Timing of Ovarian Function Suppression in Premenopausal HR+ Early-Stage Breast Cancer
Optimizing Ovarian Function Suppression in Hormone Receptor-Positive Breast Cancer: Best Practices for the Community Clinician
Loading...
We're glad to see you're enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.